Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose vitamin K added to acenocoumarol versus standard acenocoumarol for anticoagulation stability
2009-015858-38Phase 2Active
- Sponsor
- Dr. Antonio Javier Trujillo Santos
- Start
- Oct 2009
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of acenocoumarol and phytomenadione in Atrial fibrillation (AFib) and venous thromboembolism (VTE) (2 arms), sponsored by Dr. Antonio Javier Trujillo Santos. Primary endpoints: Stability of anticoagulant effect, Mean acenocoumarol dose during initiation and 1 more. Started Oct 2009; status: active.
02
Drugs
acenocoumarolphytomenadione
03
Conditions
Atrial fibrillation (AFib)venous thromboembolism (VTE)
Beyond the preview
Go deeper on 2009-015858-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015858-38.